Holen Sie sich die Stockscreener-App
10.75
1.98%
-0.1399
Schlusskurs vom Vortag:
$10.61
Offen:
$10.01
24-Stunden-Volumen:
8,910
Relative Volume:
0.01
Marktkapitalisierung:
$9.85M
Einnahmen:
$4.03M
Nettoeinkommen (Verlust:
$24.32M
KGV:
-2.4995
EPS:
-4.3008
Netto-Cashflow:
$-45.76M
1W Leistung:
-0.95%
1M Leistung:
-0.57%
6M Leistung:
-18.98%
1J Leistung:
-44.97%
1-Tages-Spanne:
$10.01
$10.69
1-Wochen-Bereich:
$9.91
$10.98
52-Wochen-Spanne:
$6.00
$28.44
Pavmed Inc Stock (PAVM) Company Profile
Firmenname
Pavmed Inc
Sektor
Branche
Telefon
(212) 949-4319
Adresse
360 MADISON AVENUE, NEW YORK, NY
Compare PAVM vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PAVM
Pavmed Inc
|
10.69 | 9.77M | 4.03M | 24.32M | -45.76M | -4.3008 |
|
ABT
Abbott Laboratories
|
110.22 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
356.34 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
89.97 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.87 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.50 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Pavmed Inc Stock (PAVM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-03-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-11-05 | Eingeleitet | Ascendiant Capital Markets | Buy |
| 2018-06-28 | Eingeleitet | Maxim Group | Buy |
Pavmed Inc Aktie (PAVM) Neueste Nachrichten
Panic Selling: Can PAVmed Inc maintain its current growth rateQuarterly Market Summary & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Earnings Risk: Whats next for PAVmed Inc stockJuly 2025 Catalysts & Safe Capital Preservation Plans - baoquankhu1.vn
PAVM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
PAVM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Levels Update: Is PAVmed Inc stock a value trapInflation Watch & Step-by-Step Trade Execution Guides - baoquankhu1.vn
Volatility Watch: Is NVR Inc stock trending bullish2025 Price Momentum & Weekly High Momentum Picks - baoquankhu1.vn
Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results - Intellectia AI
Earnings Recap: What is PAVmed Incs market position2025 Investor Takeaways & Community Shared Stock Ideas - baoquankhu1.vn
Ayrton Capital LLC Reduces Stake in Traws Pharma Inc - GuruFocus
Is PAVmed Inc. stock a value trapJuly 2025 Fed Impact & Verified Technical Trade Signals - mfd.ru
Is PAVmed Inc. stock a top performer YTDJuly 2025 Weekly Recap & Stepwise Swing Trade Plans - mfd.ru
PAVM Should I Buy - Intellectia AI
Can PAVmed Inc. sustain its profitabilityTrade Risk Assessment & Stepwise Swing Trade Plans - mfd.ru
Signal Recap: Will PAVmed Inc stock hit new highs in YEARInsider Buying & Real-Time Volume Triggers - baoquankhu1.vn
Aug Sectors: Is PAVmed Inc a potential multi baggerWeekly Gains Report & Daily Risk Controlled Trade Plans - baoquankhu1.vn
PAVmed Restructures Capital With New Preferred Financing - The Globe and Mail
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard® - Eastern Progress
PAVmed raises $45 million, restructures capital to eliminate convertible debt - Investing.com
PAVmed raises $45 million, restructures capital to eliminate convertible debt By Investing.com - Investing.com India
PAVmed Signs Multiple Financing Agreements - TradingView
PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible Securities - PR Newswire
PAVmed Inc. announced that it expects to receive $30 million in funding - marketscreener.com
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Lucid Diagnostics inks deal with VA to use esophageal cancer screen - Crain's New York Business
Technical Analysis: Is PAVmed Inc a stock for growth or value investorsMarket Performance Recap & High Return Trade Opportunity Guides - baoquankhu1.vn
What makes PAVmed Inc. stock attractive todayM&A Rumor & Consistent Profit Trading Strategies - mfd.ru
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 - Quantisnow
PAVmed subsidiary Lucid Diagnostics spikes on Veterans Affairs contract - MSN
PAVmed Regains Compliance with Nasdaq Minimum Bid Price - The Globe and Mail
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Individual investors among Lucid Diagnostics Inc.'s (NASDAQ:LUCD) largest stockholders and were hit after last week's 14% price drop - simplywall.st
What's Going On With PAVmed Shares Thursday? - Benzinga
Should you chase the rally in PAVmed stock after it quadrupled on Wednesday? - MEXC
PAVmed stock dips premarket after VA contract drives near-double rally in PAVM shares - TechStock²
Lucid Diagnostics secures VA contract for esophageal cancer test By Investing.com - Investing.com Nigeria
Crypto: PAVM at Critical Level: Why This Week Matters - InteractiveCrypto
PAVmed Inc. Stock (PAVM) Opinions on VA Contract Win - Quiver Quantitative
Nasdaq Edges Lower; Johnson & Johnson Earnings Top Estimates - Benzinga
PAVM Stock Shot Up Over 250% Today – What’s The Deal With The Department of Veterans Affairs? - Stocktwits
Why Is PAVmed Stock Skyrocketing Wednesday? - Benzinga
PAVM stock shot up over 250% today – what’s the deal with the Department of Veterans Affairs? - MSN
Dow Surges 300 Points; Netflix Shares Fall After Q4 Results - Benzinga
PAVmed Shares Soar Amid Strategic Developments and Market Reactions - timothysykes.com
Lucid Diagnostics stock surges after securing VA contract for cancer test By Investing.com - Investing.com South Africa
Lucid Diagnostics stock surges after securing VA contract for cancer test - Investing.com Canada
Why Are PAVmed (PAVM) & Lucid Diagnostics (LUCD) Stocks Up Today? - TipRanks
PAVmed-unit Lucid Diagnostics spikes on VA contract (LUCD) - Seeking Alpha
Finanzdaten der Pavmed Inc-Aktie (PAVM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.23%
1.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):